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Lipoarabinomannan(LAM)isamajorglycolipidicantigenonthemycobacterialenvelope.Theaimofthisstudywastocharacterize
the humoralimmune response induced by immunizationwith a LAM extract in bovines and to evaluate the role of the generated
antibodies in the in vitro infection of macrophages with Mycobacterium avium subsp. paratuberculosis (MAP). Sera from fourteen
calves immunized with LAM extract or PBS emulsiﬁed in Freund’s Incomplete Adjuvant and from ﬁve paratuberculosis-infected
bovines were studied. LAM-immunized calves developed speciﬁc antibodies with IgG1 as the predominant isotype. Serum
immunoglobulins were isolated and their eﬀect was examined in MAP ingestion and viability assays using a bovine macrophage
cell line. Our results show that the antibodies generated by LAM immunization signiﬁcantly increase MAP ingestion and reduce
its intracellular viability, suggesting an active role in this model.
1.Introduction
Paratuberculosis is a chronic granulomatous enteric disease
aﬀecting ruminants. The causative agent, Mycobacterium
avium subsp. paratuberculosis (MAP), enters orally, crosses
the intestinal barrier, and is phagocytized by macrophages
within the lamina propria. These cells serve as the intra-
cellular site in which MAP survives and multiplies [1, 2].
Several studies have been carried out to evaluate the MAP-
macrophage interaction, due to its importance in paratu-
berculosis pathogenesis [3]. It has been proved that various
receptors are involved in endocytosis of mycobacteria [4, 5]
and that diﬀerent routes of entry can alter the intracellular
fate of pathogens. For example, ligation to receptors for
the Fc portion of the immunoglobulins (FcR) is generally
accompanied by activation of the respiratory burst [6], and
maturation ofphagolysosomes[7],whereas uptakemediated
by complement receptors occurs in the absence of pro-
inﬂammatory signals [8].
Generally, the humoral immune response against my-
cobacterial infections has been considered nonprotective.
However, evidencefor an active role ofB cells and antibodies
in someintracellularinfectionshasbeenaccumulatedduring
the last years [9–15]. As regards paratuberculosis, it is
accepted that the humoral immune response appears late in
the infectionand probablyassociated withthe progression of
disease from a subclinical to a clinical stage [16]. However,
few works have suggested that antibodies could enhance
some immune mechanism against MAP. A recent report
has evaluated the eﬀect of immune serum on the MAP
macrophage interaction suggesting an active role of anti-
bodies [17]. In addition, our group has previously reported2 Veterinary Medicine International
that puriﬁed speciﬁc antibodies against MAP could enhance
the MAP-macrophage interaction in vitro and improve the
activation of the nuclear factor NF-κB in infected cells [18].
Lipoarabinomannan (LAM) is the main glycolipidic
antigen on the mycobacteria envelope and has a molecular
weight of approximately 40kDa. Its structure presents sim-
ilarities among pathogenic mycobacteria and diﬀerences in
relationtoLAMofnonpathogenicmembersofthegenus[19,
20]. The role ofLAM in mycobacterial pathogenesishasbeen
studied by diﬀerent research groups [21, 22]. Antibodies
against LAM have been shown to be beneﬁcial in passive
protection experiments in murine tuberculosis models [10].
As regards paratuberculosis in bovines, the serological
response against thiscompound has been extensively studied
inordertoimprovediagnosis. However,littleisknownabout
the role of LAM-speciﬁc antibodies in this infection and, to
our knowledge, there are no published reports on this topic.
The aim of this work was to characterize the humoral
immune response induced by immunization with a LAM
extract in bovines and to evaluate the role of the generated
antibodies in the in vitro infection of macrophages with
MAP.
2.Materialsand Methods
2.1. LAM Extract. Mycobacterium avium subsp. avium
(MAA) was grown to log phase in Dorset-Herley medium,
heat-inactivated and kindly provided by Dr. A. Bernardelli
(Servicio Nacional de Sanidad Animal, Argentina). The
bacterial pellet was centrifuged and resuspended in PBS
(NaH2PO4 3mM, N a 2HPO4 7.5mM, NaCl 145mM, pH
7.2–7.4) for further sonication. LAM was extracted from
5.2g of total bacteria according to the method previously
described elsewhere [23] and adapted to our laboratory con-
ditions [24]. Carbohydrate concentration was determined
by the phenol-sulphuric acid method [25]u s i n gg l u c o s e
as standard. Protein concentration was determined by the
Bradford method [26] using bovine serum albumin as
standard. Fromthese data, the percentageof protein removal
achieved was estimated as total protein amount in the LAM
extract × 100/initial total protein amount. The LAM extract
was characterized by SDS-PAGE, stained with Bio-Rad
Silver Stain (Bio-Rad Laboratories Inc., Hercules, CA, USA)
modiﬁed for carbohydrate detection [27]. Electrophoresis
was performed in a Mini-Protean II electrophoresis cell
(Bio-Rad) on 12% polyacrylamide gels, following the man-
ufacturer’s instructions. Samples containing 5μgc a r b o h y -
drate/lane were twofold diluted in sample buﬀer and heat-
treated (85◦C, 5min) before running (2h at 96mV). An
ELISA was carried out using anti-LAM of Mycobacterium
tuberculosis monoclonal antibody (mab CS-35) and puriﬁed
M. tuberculosis L A Ma sp a t t e r n( b o t hr e a g e n t sw e r ek i n d l y
provided by Dr. J. Belisle, Colorado State University, Fort
Collins, CO, USA).Flat-bottomed 96-well polystyrene plates
(Greiner Microlon, Greiner Bio-One North America Inc.,
Monroe, NC, USA) were coated with LAM extract or LAM
pattern at 25μg carbohydrate/well. An HRP-conjugated
antimouse IgG (KPL, Kirkegaard & Perry Laboratories Inc.,
Gaithsburg,MD,USA)wasusedatadilutionof1:500.Plates
were developed using ortho-phenylendiamine dihydrochlo-
ride (OPD, Sigma-Aldrich Corp., St. Louis, MO, USA) in
citrate-phosphate buﬀer (Sigma-Aldrich). The reaction was
stopped after 10min by the addition of 50μL/well of 1M
sulphuric acid, and plates were read in an OpsysMR spec-
trophotometer (Dynex Technologies, Chantilly, VA, USA).
Results are expressed in ELISA Units (EUs), estimated as the
mean opticaldensityvalueobtainedat490nm(OD)foreach
sample × 100/OD for the negative control. In this case, an
irrelevant mab was tested as negative control.
2.2.AnimalsandSamples. Atotaloffourteenﬁve-month-old
Holstein calves from tuberculosis- and paratuberculosis-free
herds from the Pampas region of Argentina were kept under
ﬁeld conditions during all the experimental period. Calves
were randomly assigned into the LAM group (n = 9), which
subcutaneously received 2mg of LAM extract dissolved in
1mL of PBS and emulsiﬁed in 1mL of Freund’s Incomplete
Adjuvant (FIA, Sigma-Aldrich),or the normal control group
(NC group, n = 5), which were mock-immunized with 1mL
of PBS emulsiﬁed in 1mL of FIA. The ﬁrst immunization
was received on day 0 and the booster 35 days later. Blood
samples were taken on days 0 and 65. This experiment
was performed under the approval and supervision of the
Institutional Committee for the care and use of experimental
animals of Facultad de Ciencias Veterinarias of Universidad
de Buenos Aires, Argentina.




fragment from isolated colonies by PCR [28].
2.3. Evaluation of Humoral Immune Response against
LAM Extract
2.3.1. ELISA. Plates were coated (4◦C, 2 days) with LAM
extract (25μg carbohydrate/well in PBS), washed three times
with rinsing buﬀer (0.05% Tween 20 in PBS) and blocked
with blocking buﬀer (0.05% Tween 20 and 10% skimmed
milk in PBS). All subsequent incubations were performed
at 37◦C for 1h and after each one, plates were washed
three times with rinsing buﬀer. For comparisons of speciﬁc
antibody levels, EUs of serum samples diluted 1:100 in
blocking buﬀer were measured. An HRP-conjugated goat
antibovine IgG (KPL) was added in a 1:1000 dilution.
For speciﬁc isotype evaluation, HRP-conjugated sheep anti-
bovine IgM, IgG1, and IgG2 antibodies (Behtyl Laboratories
Inc., Montgomery, TX, USA) diluted 1:300 and rabbit
antibovine IgG3 antibody [18] diluted 1:500 followed by
HRP-conjugated goat antirabbit IgG (KPL) diluted 1:1000
were used. Plates were developed as described above. Re-
sults are expressed in EUs, using normal control sera as
negative.
2.3.2. Immunoblot. To characterize the speciﬁcity of the
generated antibodies, immunoblots were performed using
LAM extract as antigen. Electrophoretic transfer onto nitro-
































Figure 1: Relative levels of LAM extract-speciﬁc IgG isotypes
expressed as ELISA Units (EUs) ± standard deviation of two inde-
pendent measurements for each animal at 1:100 dilution of sera.
Rad) was carried out in a Trans-Blot SD cell (Bio-Rad)
following the manufacturer’s instructions. Membranes were
incubated in blocking buﬀer and then with bovine sera
diluted 1:250. Subsequently, HRP-conjugated goat anti-
bovine IgG (KPL) was added in a 1:1000 dilution. The
reaction was developed using 0.5mg/mL DAB (HRP Color
Development Reagent 3,3 -diaminobenzidine, Bio-Rad) and
1μL/mL H2O2 100vol. in TBS buﬀer (20mM Tris, 500mM
NaCl, pH7.5) for 10min. All incubations were performed at
37◦C for 1h, and each step was followed by three washes in
rinsingbuﬀer.Inordertoconﬁrmspeciﬁcityagainstnonpro-
tein molecules, a proteolytic treatment of LAM extract with
0.2mg/mL proteinase K (Amresco Inc., Solon, OH, USA)
was performed before running the SDS-PAGE, as described
by Reichel et al. [29]. All sera were analyzed by immunoblot
against digested and undigested LAM extract. As a diges-
tion control, 1mg/mL ovalbumin (OVA, Sigma-Aldrich)
solution was incubated with proteinase K in the same
conditionsastheLAMextract.DigestedandundigestedOVA
were evaluated with a hyperimmune bovine serum against
OVA.
2.4. Precipitation and Puriﬁcation of Antibodies. Serum anti-
bodies of two animals from LAM-immunized, infected, and
normal control groups were isolated and puriﬁed for further
use in functional assays. Sera were heat-inactivated at 56◦C
for 30min. Ammonium sulfate precipitation (44% satura-
tion) was performed to obtain precipitated immunoglob-
ulins (Igs). Then, puriﬁcation by protein G aﬃnity chro-
matography (proteinG-agarose, ExalphaBiologicals,Shirley,
MA, USA) was carried out, and puriﬁed Igs were obtained.
In order to check the purity of the Igs fractions, SDS-PAGE
and electrophoresis were conducted. The concentration of
Igs was estimated by the Bradford method, considering the
percentage of gamma-globulins detected by densitometric
analysis of electrophoresis. The Igs fractions were ﬁltered by
0.22μma n ds t o r e da t– 7 0 ◦Cu n t i lu s e .
2.5. Functional Evaluation of Antibodies. These experiments
were performed using the SV40-transformed bovine peri-
toneal macrophage cell line (Bomac) [30]. Bomac cells were
cultured in RPMI-1640 medium (GIBCO, Invitrogen Corp.,
Carlsband, CA, USA) supplemented with 50μg/mL gentam-
icin (Sigma-Aldrich) and 5% foetal calf serum (Invitrogen)
at 37◦Ca n d5 %C O 2. The K-10 MAP reference strain [31],
generously provided by Dr. F. Paolicchi (Instituto Nacional
de Tecnolog´ ıa Agropecuaria, Argentina), was grown at 37◦C
in Middlebrook 7H9 broth (Difco, BD biosciences, Franklin
Lakes, NJ, USA) containing 10% albumin-dextrose-sodium
chloride, 0.05% Tween 80 (Sigma-Aldrich), and 2μg/mL
mycobactin J (Allied Monitor Inc., Fayette, MO, USA).
Titration was performed by serial dilution and seeding onto
7H9 agar plates. Stock was centrifuged and frozen at −70◦C
in 15% glycerol medium. Before use, MAP was unfrozen and
cultured overnight at 37◦C, then centrifuged, disaggregated
by passages through a 25-gauge needle, and resuspended
in RPMI medium to a ﬁnal concentration of 109 Colony
Forming Units (CFU)/mL. Multiplicity of infection was set
at 10:1 (bacteria:cell), and antibodies were used at a ﬁnal
concentration of 100μg/mL.
2.5.1. Ingestion Assay. Bomac cells (1×106 viable cells/mL)
were seeded onto 20mm×20mm sterile coverslips, allowed
to adhere for 2h and incubated overnight in RPMI medium.
Bacteria were opsonized with precipitated Igs (100μg/mL)
from LAM-immunized, infected or normal control bovines,
at 37◦C for 1h in a shaker. Immediately prior to inoculation
of monolayers, the bacterial suspension was disaggregated as
described above. MAP-macrophages interaction was allowed
for 45min. Cells were washed with cold PBS, ﬁxed with
0.37%formaldehyde,and stainedwith Ziehl-Nielsen.Amin-
imumof100cells/coverslipwer ecountedinimmersionﬁelds
(1000x) by light microscopy. The percentage of phagocytic
cells (%PhC) and the mean number of internalized MAP
detected in each cell (iMAP) were recorded. The phagocytic
index (PI) was calculated as % PhC×iMAP [32].
2.5.2. Intracellular Viability Assay. To evaluate the viability
of ingested MAP, Bomac cells (1×106 viable cells/mL) were
seeded onto 24-well tissue culture plates and incubated at
37◦C overnight in 5% CO2. Bacteria were opsonized and
disaggregated as described above. Then, inoculated into
Bomac cultures, in duplicate. After 2h, monolayers were
washed with PBS and one of each duplicate well was lysed
with 0.2% sodium dodecylsulfate for initial CFU counting.
The other duplicate well was incubated with RPMI medium
containing 0.1mg/mL gentamicin for 2h in order to avoid
contamination [33], then replacing it with antibiotic-free
medium. Infected macrophages were cultured for 72h and
thenlysedforﬁnalCFUcounting.Lysateswereseriallyplated
on 7H9 agar and cultured at 37◦C for 5 weeks until the CFU
were counted. Results are expressed as percent change in
viability(ﬁnalCFU/initialCFU×100).Additionally,anFcR-
blocking assay was conducted as described by Manca et al.
[34]. Bomac cells were preincubated for 1h with 100μg/mL
of protein G-puriﬁed Igs from a normal control bovine that
















Figure2:(a)CharacterizationofLAMextractbySDS-PAGE(lane1:puriﬁed LAMofM.tuberculosis, lane2:LAMextract, bothsilver-stained
for carbohydrate detection) and immunoblot. (lane 3: LAM extract reactivity assessed against one representative serum from the infected
control group). (b) Immunoblot of bovine sera reactivity against LAM extract. Left side of the dotted line: LAM extract was run as antigen.
D andUD indicate protein-digested orundigested antigen. 1, 2 and 3 showresults of three representative sera from LAM-immunizedgroup.
Normal control shows results representative for sera in that group. Right side of the dotted line: ovalbumin (OVA) was run as antigen and
reactivity assessedagainstserumofanOVA-immunizedbovine, asa positivecontrol ofprotein digestion.MWM:molecularweight markers.
2.6. Statistical Analysis. Data were analyzed for statistical
signiﬁcance using STATISTIX8.0software. ANOVAfollowed
by Tukey’s test was used except for isotype analysis. In that
case, Kruskal-Wallis test followed by pairwise comparisons
was run. The level of signiﬁcance was set at P value <.05.
3.Results
3.1.Characterization ofLAMExtract. Weobtainedanextract
containing 105mg of total carbohydrate. Protein presence
waslargelyreduced(46.8mgofproteininitiallyversus0.4mg
of residual protein in the LAM extract), thus showing a
percentage of protein removal of 99.2%. SDS-PAGE results
demonstrated that the LAM extract was mostly composed
of a carbohydrate mixture, as revealed by the presence of
many bands when modiﬁed silver stain was performed.
Indeed, the predominant component migrated similar to M.
tuberculosis LAM (Figure 2(a), lane 1 and 2). As expected,
sera from the MAP-infected control group recognized our
LAM extract of MAA (Figure 2(a), lane 3). In the mab
CS35-ELISA, the result obtained for our LAM extract was
493.5±35.1EU,whereasforpuriﬁedtuberculosisLAMitwas
657.8 ± 10.6EU. These results show cross reactions between
LAM of pathogenic mycobacteria.
3.2. Humoral Immune Response against LAM Extract. The
reactivity of sera against LAM extract was assessed and the
level of speciﬁc antibodies and the isotypic proﬁle were
determined. All the calves in the LAM group generated a
speciﬁc humoral immune response, with antibody levels at
1:100 serum dilution between 180 and 790EU. Comparable
levels were detected in the infected control group (range
between180and723EU).Asregardstheisotypeanalysis, the
presence ofspeciﬁc IgM, IgG1, IgG2, and IgG3 was evaluated
in sera from LAM-immunized, infected, and normal control
bovines. We could not detect speciﬁc IgM (LAM group
106.8 ± 5.5EU , ICgroup 97.9 ± 15.8EU, NC group 101.6
± 8.1EU). The results obtained for speciﬁc IgG1, IgG2, and
IgG3 are shown in Figure 1. The humoral immune response
of LAM-immunized bovines was mostly predominated by
IgG1 with minor presence of IgG2 and IgG3, although
statistically signiﬁcant diﬀerences were found for the three
of them when comparing with the normal control group
(P<. 05). In the infected control group, a similar trend
was detected, with IgG1 as the only isotype with levels
signiﬁcantly higher than in the normal control group.
Sera were also tested against the LAM extract by
immunoblot assay (Figure 2(b)). For all LAM-immunized
calves, only one band of molecular weight between 25 and
50kDa was detected. This band remained at equal strength
after proteolytic digestion of the extract, demonstrating the
nonprotein nature of the antigen involved (Figure 2(b),D
versus UD lanes).
3.3. Functional Eﬀects of Antibodies. The precipitated and
puriﬁed Igs obtained (Figure 3(b), boxes) were used in
functional assays.
Eﬀect on MAP Ingestion. As shown in Figure 3(a),o p s o n i z a -
tion of MAP with speciﬁc antibodies increased the ingestion
of bacteria. The antibodies from both LAM-immunized
a n di n f e c t e dc o n t r o lb o v i n e ss h o w e dap h a g o c y t i ci n d e x












































































































(1) Precipitated Igs (2) Puriﬁed Igs
P<. 01 P<. 05
(b)
Figure 3: Functional eﬀects of antibodies: (a) on MAP ingestion. Results are expressed as mean phagocytic index for each treatment ±
standard deviation; (b) on MAP intracellular viability. Results are expressed as % change in MAP viability 72h after the ingestion by Bomac
cells. Boxes are representative of electrophoretic (lane 1) and SDS-PAGE (lane 2) pattern of precipitated and puriﬁed Igs. α and γ indicate
alpha- and gamma- globulins bands. MWM: molecular weight markers. Error bars indicate standard deviation of three independent assays
and diﬀerent letters or numbers over bars represent signiﬁcant diﬀerences between groups.
opsonizingMAPwithnormalcontrolantibodies(phagocytic
index of 59.4, 61.5, and 33.2, resp.).
Eﬀect on MAP Intracellular Viability. When assays were con-
ducted by opsonizing MAP with precipitated antibodies,
LAMgroupIgssigniﬁcantlyreduced(P<. 05)thepercentage
of MAP viability, as compared with that obtained for normal
and infected control Igs opsonization (Figure 3(b)(1)).
When MAP was opsonized with puriﬁed Igs, compa-
rable and more repeatable results were obtained for LAM-
immunized and normal control groups (P<. 01). For
the infected control group, the result was similar to that
of the treatment with LAM group Igs. Preincubation of
macrophages with aggregated Igs (FcR blockade) resulted in
a signiﬁcant increase of MAP viability as compared with the
eﬀect of antibodies from LAM group without previous incu-
bation with aggregated Igs (P<. 05) (Figure 3(b)(2)). This
result suggests that the eﬀect observed for the opsonization
with LAM group Igs could be FcR-mediated.
4.Discussion
In the present work, we examined the immune response
induced in cattle by immunization with a LAM extract
and the eﬀect of the generated antibodies in the MAP-
macrophage interaction.
We used MAA for LAM extraction instead of MAP
due to the antigenic homology between both [29]a n dt h e6 Veterinary Medicine International
faster growth in culture of the former. Besides, our ELISA
and immunoblot results support cross reactions among
mycobacterial glycolipids previously described [19, 20, 29]
and show that the method of LAM extraction applied
preserved its antigenicity. To our knowledge, this is the ﬁrst
report of bovine immunization using a mycobacterial LAM
extract. With the immunization protocol used, we were able
to induce high levels of speciﬁc antibodies with increases of
all IgG isotypes and the predominance of IgG1 in most of
thestudiedcalves.IgG1wasalsodetectedasthepredominant
isotype in the infected control group. Similar responsiveness
against LAM was previously described in bovines with
clinical paratuberculosis [35]. Taking into account that this
isotype represents the most relevant immunoglobulin in
mammary gland secretions of bovines [36], the presence
of local speciﬁc IgG1 might be relevant for the passive
protection of newborn calves.
The inﬂuence of opsonization with antibodies on MAP
phagocytosis and intracellular viability has been previously
evaluated [17, 18, 33, 37, 38]. However, published reports
have been generally based on assays where total serum
was examined as a source of antibodies. While many other
serum components are known to possess opsonic activity
andcouldaﬀectintracellular viabilityofbacteria,we puriﬁed
Igs for functional evaluation. The puriﬁcation methodology
applied was successful. However, a heavy band was observed
in SDS-PAGE, probably corresponding to the presence of
incompletely reduced Igs molecules, as suggested by the
reactivitywithanantibovine IgGantibody (datanotshown).
We found that the phagocytic level of Bomac cells
increased almost twofold when MAP was opsonized with
antibodiesfrom eitherLAM-immunized orinfected bovines.
MAP-phagocytosis enhancement by hyperimmune sera has
been previously reported in Bomac cells [18] and bovine
blood monocyte-derived macrophages (BMDMs) [17, 37].
The phagocytic levels detected herein were comparable to
those published by Woo et al. for Bomac cells [38], although
our indexes were lower than those described for BMDM
when ingesting MAP [17, 37]. Therein, the kinetics of
MAP uptake was evaluated and a signiﬁcant increase in the
ingestionlevelwas detectedafter60 to 120min ofincubation
[17,37].Taking theseobservationsintoaccount,itispossible
that the lower phagocytic index detected herein could be
related to the shorter MAP-macrophages incubation time or
to the use of Bomac cell line instead of BMDM.
Controversial results in viability assays opsonizing MAP
with whole sera from healthy and infected bovines were
published [17, 37, 38]. In our model, opsonization with
precipitated Igs from normal and infected bovines shows a
beneﬁcial eﬀect on MAP viability. However, we found diﬀer-
ent results when precipitated and puriﬁed Igs from infected
bovines were used for opsonization. The presence of other
opsonins in precipitated Ig fractions, such as collectins, C-
Reactive protein, or ﬁbronectin, could explain the diﬀerence
found [39–41]. Noteworthy, our results show that antibodies
induced by LAM immunization could signiﬁcantly reduce
the intracellular viability of MAP.
These results raise questions about the biological rele-
v a n c eo fL A Ma n t i b o d i e si np a r a t u b e r c u l o s i s .W eh e r ef o u n d
that puriﬁed antibodies present in sera from bovines immu-
nized with LAM of MAA could reduce MAP intracellular
viability as well as antibodies from MAP clinically infected
cattle. However, in the natural infection, the antibodies
appear late and probably associated with the progression
of disease. It remains to be established whether speciﬁc
antibodies present at the moment of the infection could
modify the course of paratuberculosis.
Our ﬁndings provide new data about basic aspects of
the role of antibodies in MAP-macrophage infection in
vitro. More studies, using other MAP strains, especially ﬁeld
isolates, and macrophages derived directly from bovines,
must be conducted in order to better approach to the role of
antibodies in the natural MAP-macrophage interaction that
takes place in the host.
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